Raphael Pharmaceutical (RAPH) Other Working Capital Changes (2020 - 2025)

Raphael Pharmaceutical has disclosed Other Working Capital Changes across 6 years of filings, most recently posting -$6000.0 for Q3 2025.

• In Q3 2025, Other Working Capital Changes fell 300.0% year-over-year to -$6000.0; the TTM figure through Sep 2025 stood at -$7000.0 (down 216.67% YoY), while the FY2024 annual figure was -$1000.0, up 97.22% from the prior year.
• Other Working Capital Changes came in at -$6000.0 for Q3 2025 at Raphael Pharmaceutical, up from -$33000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $244000.0 in Q4 2021 to a low of -$170000.0 in Q1 2022.
• Average Other Working Capital Changes over 5 years is -$11894.7, with a median of -$4000.0 recorded in 2021.
• The largest YoY upside for Other Working Capital Changes was 483.33% in 2025 against a maximum downside of 371.43% in 2025.
• Over 5 years, Other Working Capital Changes stood at $244000.0 in 2021, then plunged by 93.03% to $17000.0 in 2022, then slumped by 76.47% to $4000.0 in 2023, then tumbled by 175.0% to -$3000.0 in 2024, then tumbled by 100.0% to -$6000.0 in 2025.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$6000.0 in Q3 2025, -$33000.0 in Q2 2025, and $35000.0 in Q1 2025.